U.S. Markets closed

Covalon Technologies Ltd. (COV.V)

TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
4.30+0.05 (+1.18%)
At close: 4:16PM EDT
People also watch
CZO.VRX.VHTL.VMBX.TOCOT.V

Covalon Technologies Ltd.

1660 Tech Avenue
Unit 5
Mississauga, ON L4W 5S7
Canada
905-568-8400
http://www.covalon.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedAge
Mr. Abe SchwartzChairman & Advisor162.72kN/AN/A
Mr. Brian E. PedlarChief Exec. Officer, Pres & Director442kN/AN/A
Mr. Danny BrannaganChief Financial Officer134.53kN/AN/A
Ms. Kim CrooksVP of Operations172.76kN/AN/A
Mr. John HandsExec. VP & VP - Marketing161.83kN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Covalon Technologies Ltd. researches, develops, manufactures, markets, and licenses medical products in the areas of advanced wound care, infection management, and surgical procedures worldwide. The company offers Collagen Matrix platform to develop products for the treatment of donor and graft sites, traumatic and surgical wounds, and first and second degree burns, as well as diabetic, pressure, and venous ulcers; Antimicrobial Silicone Adhesive platform, a pre-surgical, post-surgical, and vascular access products; and medical coating platform CovaCoat, a technology that provides photochemical process for covalently linking coating molecules to various medical device surfaces. Its medical coatings deliver infection control, therapeutic delivery, and lubricity. The company also provides services, such as feasibility studies, product formulation, prototype testing, validation, regulatory clearances, and manufacturing. In addition, it offers wound care products comprising ColActive Plus Ag collagen matrix dressings; ColActive Transfer wound contact layers; and CovaWound advanced wound care dressings. Further, the company provides IV Clear and SurgiClear antimicrobial silicone dressings. It offers its technologies, products, and services to medical device companies; healthcare providers, such as hospitals, wound care centers, burn centers, extended/alternate care facilities, acute care facilities, home health care agencies, and physicians’ offices; and individual consumers. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.

Corporate Governance

Covalon Technologies Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.